Consent of Proposed Director
Exhibit 99.6
I, Xxxxxx Xxxxxx, hereby consent to the following:
| ● | to serve as a director of the Resulting Issuer (as defined herein) if the transactions contemplated by the Amalgamation Agreement, dated January 10, 2020 (as amended on May 6, 2020 and May 26, 2020 and as may be further amended, the “Amalgamation Agreement”), by and among AMERI Holdings, Inc. (“Ameri”, and after giving effect to the Amalgamation and the consummation of the transactions contemplated by the Amalgamation Agreement, the “Resulting Issuer”), Xxx Xxxxxx Merger Sub, Inc., a wholly owned subsidiary of Ameri (“Merger Sub”), Xxx Pharma Inc. (“Xxx Xxxxxx”), 1236567 B.C. Unlimited Liability Company (“ExchangeCo”) and Xxxxx Xxxxxxxx are consummated, including the amalgamation of Merger Sub and Xxx Pharma into one corporation to continue as a direct wholly-owned subsidiary of ExchangeCo and an indirect wholly-owned subsidiary of Ameri (collectively, the “Amalgamation”); |
| ● | to be named as a proposed director of the Resulting Issuer in the Registration Statement on Form S-4, including the joint proxy statement/prospectus, to be filed by Ameri in connection with the Amalgamation, and in any and all amendments and supplements thereto (collectively, the “Registration Statement”); and |
| ● | to the filing of this consent as an exhibit to the Registration Statement. |
| /s/ Xxxxxx Xxxxxx | Date: | May 26, 2020 | |
| Xxxxxx Xxxxxx |
